CDH1 and central nervous system cancer: Data on E-cadherin, whose expression is, on the contrary, fairly absent in gliomas, proposes E-cadherin loss as a potential step in glioma genesis, as the expression is more frequent in low-grade gliomas than in glioblastoma [144,145].